FIGURE 2.

Experimental disease contexts used to evaluate ROS-responsive cardiovascular biomaterials. The figure aligns biological disease chronology with pretreatment, acute transient ischemia-reperfusion, established MI, and chronic remodeling models. The separation between reperfused and non-reperfused injury emphasizes that these settings test different delivery and therapeutic questions. Evidence-depth indicators distinguish predominantly rodent studies from the limited ex vivo and large-animal evidence (Prepared with the assistance of Gemini NotebookLM pro and OpenAI ChatGPT Plus).